Nordic Pharma Lab ApS — Credit Rating and Financial Key Figures

CVR number: 39161672
Slotsmarken 12, 2970 Hørsholm

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit-41.00- 106.00-24.00-19.00-18.92
Total depreciation- 178.00
EBIT-41.00- 284.00-24.00-19.00-18.92
Other financial expenses-9.00-10.00-11.66
Pre-tax profit-41.00- 284.00-33.00-29.00-30.57
Income taxes21.001.001.00
Net earnings-20.00- 283.00-33.00-28.00-30.57

Assets (kDKK)

2020
2021
2022
2023
2024
Development expenditure91.00
Intangible rights88.00
Intangible assets total179.00
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables7.002.004.00
Current deferred tax assets22.00
Short term receivables total29.002.004.00
Cash and bank deposits4.0027.004.004.005.27
Cash and cash equivalents4.0027.004.004.005.27
Balance sheet total (assets)212.0029.008.004.005.27

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital100.00100.00100.00100.00100.00
Other reserves71.00
Retained earnings-94.00-43.00- 326.00- 360.00- 387.94
Profit of the financial year-20.00- 283.00-33.00-28.00-30.57
Shareholders equity total57.00- 226.00- 259.00- 288.00- 318.51
Provisions1.00
Non-current liabilities total
Current trade creditors28.0016.0019.0015.0015.00
Current owed to group member110.00224.00248.00277.00308.78
Other non-interest bearing current liabilities16.0015.00
Current liabilities total154.00255.00267.00292.00323.78
Balance sheet total (liabilities)212.0029.008.004.005.27
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.